SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615774-18-000934
Filing Date
2018-02-07
Accepted
2018-02-07 17:02:56
Documents
39
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q s108935_10q.htm 10-Q 530435
2 EXHIBIT 31.1 s108935_ex31-1.htm EX-31.1 9268
3 EXHIBIT 31.2 s108935_ex31-2.htm EX-31.2 9478
4 EXHIBIT 32.1 s108935_ex32-1.htm EX-32.1 8133
  Complete submission text file 0001615774-18-000934.txt   2462274

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE avxl-20171231.xml EX-101.INS 505199
6 XBRL SCHEMA FILE avxl-20171231.xsd EX-101.SCH 25931
7 XBRL CALCULATION FILE avxl-20171231_cal.xml EX-101.CAL 24963
8 XBRL DEFINITION FILE avxl-20171231_def.xml EX-101.DEF 84305
9 XBRL LABEL FILE avxl-20171231_lab.xml EX-101.LAB 207471
10 XBRL PRESENTATION FILE avxl-20171231_pre.xml EX-101.PRE 134524
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

IRS No.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37606 | Film No.: 18581820
SIC: 8731 Services-Commercial Physical & Biological Research